Novo Nordisk (NVO) and Eli Lilly's (LLY) weight loss drugs lead Evaluate Pharma’s list of best-selling drugs projected for ...

Honda and Nissan’s planned merger, set for 2026, is risky due to potential integration issues. Read why I think investors ...

Schwab U.S. Dividend Equity ETF is a clear buy with a look at its top 10 holdings. Click here to why I rate SCHD a Buy.

Super Micro Computer benefits from AI-driven demand for liquid cooling. Read why SMCI stock has significant upside with ...

Ramaco Resources, Inc.'s new 8.375% Senior Notes due 2029, METCZ, have increased the company's debt-to-equity ratio from 0.25 ...

Apple is a top tech pick for 2025 with strong financials, product differentiation, and AI-driven growth potential. Click here ...

Smithfield Foods plans a $100 million IPO to expand infrastructure. Learn why SFD stock could benefit from global pork market ...

HIVE Digital offers a strong risk/reward with a potential double bottom at $2.80. Learn why HIVE stock is a compelling buy if ...

A look at the performance of the technology, media, and telecommunications sector in 2024 and its impact on the overall ...

Root Inc. uses telematics to offer car insurance based on driving behavior. Learn why ROOT stock is undervalued and a strong ...

Ivanhoe Mines plans to ramp up copper and zinc production in 2025 at Kamoa-Kakula and Kipushi projects in the Congo after ...

Roche's strategic acquisition of Poseida Pharmaceuticals positions them as a leader in the allogeneic cell therapy market.